Harvard Bioscience
HBIO
HBIO
69 hedge funds and large institutions have $66M invested in Harvard Bioscience in 2016 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 27 increasing their positions, 17 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
1% less funds holding
Funds holding: 70 → 69 (-1)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
69
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.53M | |
| 2 | +$661K | |
| 3 | +$453K | |
| 4 |
FP
Foundry Partners
Minneapolis,
Minnesota
|
+$370K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$351K |
Top Sellers
| 1 | -$2.85M | |
| 2 | -$1.58M | |
| 3 | -$915K | |
| 4 |
MOACM
Mutual of America Capital Management
New York
|
-$680K |
| 5 |
RA
Royce & Associates
New York
|
-$450K |